Loading insider details...
Beta
Latest Form 4 (Jul 10, 2026): Exercise/Conversion of 1,015 CTNM shares, $1.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 10, 2026 | Contineum Therapeutics, Inc. (CTNM) | Exercise/Conversion | 1,015 | $1.0K |
| Jul 2, 2026 | Contineum Therapeutics, Inc. (CTNM) | Exercise/Conversion | 28,826 | $29.1K |
| Jun 1, 2026 | Contineum Therapeutics, Inc. (CTNM) | Sale | 4,170 | $54.9K |
| May 1, 2026 | Contineum Therapeutics, Inc. (CTNM) | Sale | 3,870 | $50.5K |
| Apr 6, 2026 | Contineum Therapeutics, Inc. (CTNM) | Sale | 4,170 | $56.0K |
| Mar 2, 2026 | Contineum Therapeutics, Inc. (CTNM) | Sale | 4,170 | $62.6K |
| Feb 26, 2026 | Contineum Therapeutics, Inc. (CTNM) | Exercise/Conversion | 4,300 | $4.3K |
| Feb 20, 2026 | Contineum Therapeutics, Inc. (CTNM) | Exercise/Conversion | 100 | $101.00 |
| Feb 13, 2026 | Contineum Therapeutics, Inc. (CTNM) | Exercise/Conversion | 400 | $404.00 |
| Feb 5, 2026 | Contineum Therapeutics, Inc. (CTNM) | Sale | 3,000 | $44.5K |